Ravi Patel

Thrilled to start 1/2026 as Chief of CV Medicine and Co-Director of the CV Institute @IUMedSchool / @IU_Health! Grateful for lifelong friends, colleagues, trainees @ NUFSM & continuing collabs. Excited for what's to come at IUSM/IUH! @IUSMDeptMed @saraj_pereira @IUCVInstitute

ANOTHER round of Top Site-Coordinators who have proven their dedication to the CV ecosystem through their impressive work in HF trials. Join us in congratulating all of our Site-Based Research award winners! 🎉 #AHA #AHA24 hfcollaboratory.com/awards

@MattFeinsteinMD joins us from @NUFeinbergMed @NMCardioVasc to discuss the complex immune system modifiers of cardiovascular disease. Wow. My head is spinning. So much to discuss with him today! @NMHheartdoc @HFpEF @WilcoxHeart @HeartDocSadiya have compelling reasons to be proud of the work being done there. @MkosiborodMD @jspertus @MidAmericaHeart

In this #JACCBTS analysis, a common missense variant of ICAM-1 among African American individuals that has been associated with #HFpEF appears to be associated with circulating inflammatory proteins. Get the details: bit.ly/3TVqwMZ

In a large cohort of African-American women, the ICAM1 missense variant rs5491 (p.Lys56Met) was specifically associated with #HFpEF hospitalization among individuals starting at the age of 70 years. bit.ly/4ePcDaP #JACCHF #HeartFailure #cvGenetics

REBALANCE-HF trial: While splanchnic ablation for volume management (SAVM) did not reduce PCWP in HFpEF overall, subgroup analysis suggests benefits in patients with preserved cardiac output during exercise and less severe diastolic dysfunction. ja.ma/3TSNYKv

Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. ja.ma/4dljU0X #HFSA2024

Immune cell profiling of the ICAM1 p.K56M heart failure with preserved ejection fraction risk variant - PubMed pubmed.ncbi.nlm.nih.gov/39034892/

Feinberg investigators have been selected to lead a $15 million @American_Heart research initiative studying the role of #inflammation in #HeartDisease. spr.ly/6019bcpfF

Over 2 years of follow-up, atrial shunting in patients with HFpEF and HFmrEF led to reverse remodeling of left-sided chambers and increases in volume of right-sided chambers but no change in RV systolic function compared with sham. ja.ma/3Q2LuHC

Amazing job by our fellow presenters and faculty moderators this morning recapping top line results from @ACCinTouch! @RBPatelMD @ALewisMD @NMCardioVasc @M_Leya27

@NMHheartdoc @NMCardioVasc @jessquagginsmi1 @WeAreNUHeart @American_Heart @docbfreed @VorovichHeartMD @WilcoxHeart @HeartDocSadiya @HFpEF @dmljmd @SusanQuaggin Congratulations @jessquagginsmi1 and @WeAreNUHeart fellows for research awards and excellent presentations of ACC24 LBCTs!

Cardiology Grand Rounds @NMCardioVasc - recap #LBCT #ACC2024 - outstanding fellow led discussions. Will practice change? New hypotheses? PLUS 2 announcements: @jessquagginsmi1 - Bonow research proposal award winner & @WeAreNUHeart won @American_Heart fellow research award grant👏🏽

On Day 1 at #ACC24, Northwestern Medicine Bluhm Cardiovascular Institute resident, Kasen Culler, MD (@CullerKasen), presents his poster on the effect of #MetabolomicProfiling on #MyoInositol #metabolism in early #HeartFailure.

Please help us congratulate Mercedes Carnethon, PhD (@MCarnethon), who has been named the chair of the Department of Preventive Medicine! 👏 spr.ly/6017wDwZF

What's the mechanism by which cellular adhesion molecules are associated with #AFib and HFpEF? Read insights from the Multi‐Ethnic Study of Atherosclerosis (MESA) about VCAM-1 and ICAM-1. #AHAJournals @GrahamPeigh @RBPatelMD @NMCardioVasc ahajournals.org/doi/10.1161/JA…

More than 6 million people in the U.S. have heart failure, making it one of the leading causes of hospitalization in the country. @NUFeinbergMed Prof. Sanjiv Shah (@HFpEF) explains how his team uses AI in diagnosis, and how it can improve health care: bit.ly/3UUPUn2

Now out in @JAMANetworkOpen , @artschuermans and I w/ Alex Reiner @fredhutch examine the role of clonal hematopoiesis of indeterminate potential (CHIP) 🩸🧬 in future/incident development of heart failure and its subtypes (HFpEF and HFrEF) jamanetwork.com/journals/jaman… 👇 (1/X)

@NiruKrishMD @MaryWhooley @schopfermd @Aziz_Nagar @FrannyBartoli @AikawaElena @mandyturner_ @toleafgirl From LaPenna et al: Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model @kyle_lapenna @andrewlizhen @Sharp_Lab @RBPatelMD @HFpEF ahajournals.org/doi/10.1161/JA…